Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for AdaptHealth (AHCO) over the last 7 years, with Q2 2025 value amounting to $32.2 million.

  • AdaptHealth's Other Operating Expenses changed N/A to $32.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1186.49%. This contributed to the annual value of $2.3 billion for FY2024, which is 2629.85% down from last year.
  • According to the latest figures from Q2 2025, AdaptHealth's Other Operating Expenses is $32.2 million.
  • In the past 5 years, AdaptHealth's Other Operating Expenses ranged from a high of $1.1 billion in Q3 2023 and a low of $32.2 million during Q2 2025
  • For the 5-year period, AdaptHealth's Other Operating Expenses averaged around $555.3 million, with its median value being $561.1 million (2022).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 13000.99% in 2021, then tumbled by 2595.6% in 2024.
  • Quarter analysis of 5 years shows AdaptHealth's Other Operating Expenses stood at $543.7 million in 2021, then fell by 15.19% to $461.1 million in 2022, then soared by 72.94% to $797.4 million in 2023, then fell by 25.96% to $590.5 million in 2024, then crashed by 94.54% to $32.2 million in 2025.
  • Its Other Operating Expenses stands at $32.2 million for Q2 2025, versus $578.7 million for Q1 2025 and $590.5 million for Q4 2024.